Choi, Kui Son , Park, Eun Cheol , Lim, Min Kyung , Lim, Jin Hwa , Kim, Sung Gyeong , Park, Jae Hyun , Jeong, Seung Yong , Park, Ji Won , Lim, Seok Byung , Choi, Hyo Seong , Jung, Kyung Hae , Kim, Dae Yong , Park, Jae Gahb
PURPOSE The incidence of cancer incidence and the rate of mortality are increasing in Korea. Specifically, colorectal cancer in men is one of the most sharply increasing malignancies. The objective of this study was to assess the direct costs for colorectal cancer patients and to identify the factors that influence cancer costs. METHODS The direct costs of colorectal cancer were examined with a prospective group study at a hospital. The direct costs were assessed every 3 months over a 24-month period through patient interviews, medical records, and claims data. We identified the major factors associated with the cost of colorectal cancer by using a general linear model for the log-transformed data. RESULTS The group was comprised of 100 patients with colon cancer and 120 patients with rectal cancer. The average costs per patient during the first and the second years after diagnosis were 16,280,000 won and 5,786,000 won respectively. Medical costs accounted for about 68% (11,090,000 won) of the first year's total cost and about 62% (3,602,000 won) of the second year's total cost.
National Health Insurance (NHI) paid approximately 50% of the total medical cost. The total cost of colorectal cancer was clearly associated with the stage of the disease at first diagnosis, the cancer site, therapeutic modalities, and recurrence. CONCLUSIONS These results indicate that colorectal cancer has a heavy financial impact on cancer patients. The total cost of colorectal cancer is clearly associated with the stage of the disease at first diagnosis. Increased efforts in terms of prevention and early detection may assist in reducing the costs.
Citations
Citations to this article as recorded by
Financial burden of colorectal cancer treatment among patients and their families in a middle-income country Meram Azzani, April Camilla Roslani, Tin Tin Su Supportive Care in Cancer.2016; 24(10): 4423. CrossRef
Palliative treatment of colorectal cancer in Germany: cost of care and quality of life Martin Emmert, Katharina Pohl-Dernick, Axel Wein, Frank Dörje, Susanne Merkel, Frank Boxberger, Gudrun Männlein, Robert Joost, Hans-Detlev Harich, Roland Thiemann, Christof Lamberti, Markus F. Neurath, Werner Hohenberger, Oliver Schöffski The European Journal of Health Economics.2013; 14(4): 629. CrossRef
Costs of Initial Cancer Care and its Affecting Factors So Young Kim, Sung Gyeong Kim, Jong Hyock Park, Eun Cheol Park Journal of Preventive Medicine and Public Health.2009; 42(4): 243. CrossRef